Pekin Hardy Strauss’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $427K | Hold |
4,125
| – | – | 0.04% | 339 |
|
|
2026
Q1 | $296K | Sell |
4,125
-752
| -15% | -$57.9K | 0.03% | 370 |
|
|
2025
Q4 | $387K | Buy |
4,877
+552
| +13% | +$43.5K | 0.04% | 310 |
|
|
2025
Q3 | $326K | Hold |
4,325
| – | – | 0.03% | 318 |
|
|
2025
Q2 | $298K | Sell |
4,325
-250
| -5% | -$16.4K | 0.03% | 302 |
|
|
2025
Q1 | $310K | Hold |
4,575
| – | – | 0.04% | 282 |
|
|
2024
Q4 | $205K | Sell |
4,575
-6,175
| -57% | -$346K | 0.03% | 334 |
|
|
2024
Q3 | $676K | Sell |
10,750
-1,065
| -9% | -$62.1K | 0.09% | 207 |
|
|
2024
Q2 | $698K | Buy |
11,815
+50
| +0.4% | +$3.13K | 0.1% | 179 |
|
|
2024
Q1 | $938K | Sell |
11,765
-1,400
| -11% | -$107K | 0.13% | 147 |
|
|
2023
Q4 | $1.04M | Sell |
13,165
-6,335
| -32% | -$451K | 0.15% | 137 |
|
|
2023
Q3 | $1.36M | Sell |
19,500
-1,100
| -5% | -$77.9K | 0.22% | 112 |
|
|
2023
Q2 | $1.42M | Sell |
20,600
-1,265
| -6% | -$90K | 0.16% | 112 |
|
|
2023
Q1 | $1.62M | Buy |
21,865
+450
| +2% | +$37.7K | 0.22% | 102 |
|
|
2022
Q4 | $2M | Sell |
21,415
-295
| -1% | -$28.5K | 0.27% | 84 |
|
|
2022
Q3 | $2.07M | Sell |
21,710
-875
| -4% | -$86.6K | 0.33% | 79 |
|
|
2022
Q2 | $2.09M | Buy |
22,585
+300
| +1% | +$29.3K | 0.3% | 87 |
|
|
2022
Q1 | $2.25M | Buy |
22,285
+420
| +2% | +$44.1K | 0.28% | 86 |
|
|
2021
Q4 | $2.26M | Buy |
21,865
+550
| +3% | +$50.8K | 0.31% | 94 |
|
|
2021
Q3 | $1.81M | Buy |
21,315
+3,590
| +20% | +$301K | 0.26% | 103 |
|
|
2021
Q2 | $1.48M | Sell |
17,725
-1,245
| -7% | -$102K | 0.21% | 119 |
|
|
2021
Q1 | $1.43M | Sell |
18,970
-3,317
| -15% | -$242K | 0.23% | 106 |
|
|
2020
Q4 | $1.52M | Buy |
22,287
+480
| +2% | +$31.2K | 0.26% | 96 |
|
|
2020
Q3 | $1.27M | Buy |
21,807
+3,387
| +18% | +$211K | 0.26% | 90 |
|
|
2020
Q2 | $1.2M | Buy |
18,420
+4,312
| +31% | +$272K | 0.26% | 86 |
|
|
2020
Q1 | $837K | Sell |
14,108
-2,230
| -14% | -$149K | 0.19% | 97 |
|
|
2019
Q4 | $1.21M | Buy |
16,338
+665
| +4% | +$46.7K | 0.2% | 93 |
|
|
2019
Q3 | $989K | Buy |
15,673
+6,995
| +81% | +$415K | 0.19% | 96 |
|
|
2019
Q2 | $473K | Buy |
8,678
+4,095
| +89% | +$221K | 0.09% | 138 |
|
|
2019
Q1 | $247K | Buy |
4,583
+1,072
| +31% | +$66.2K | 0.02% | 173 |
|
|
2018
Q4 | $230K | Sell |
3,511
-398
| -10% | -$29.7K | 0.04% | 171 |
|
|
2018
Q3 | $308K | Buy |
+3,909
| New | +$279K | 0.05% | 157 |
|
|
2017
Q4 | – | Sell |
-2,526
| Closed | -$205K | – | 195 |
|
|
2017
Q3 | $205K | Sell |
2,526
-113
| -4% | -$8.94K | 0.04% | 173 |
|
|
2017
Q2 | $212K | Sell |
2,639
-51
| -2% | -$4.03K | 0.03% | 166 |
|
|
2017
Q1 | $211K | Buy |
2,690
+1
| +0% | +$80 | 0.04% | 163 |
|
|
2016
Q4 | $212K | Sell |
2,689
-1,349
| -33% | -$109K | 0.02% | 156 |
|
|
2016
Q3 | $359K | Sell |
4,038
-490
| -11% | -$46.3K | 0.06% | 116 |
|
|
2016
Q2 | $433K | Sell |
4,528
-1,001
| -18% | -$99.8K | 0.1% | 103 |
|
|
2016
Q1 | $574K | Buy |
5,529
+154
| +3% | +$15K | 0.13% | 91 |
|
|
2015
Q4 | $526K | Buy |
+5,375
| New | +$526K | 0.12% | 99 |
|
|
2015
Q1 | – | Sell |
-14,215
| Closed | -$1.37M | – | 164 |
|
|
2014
Q4 | $1.37M | Buy |
+14,215
| New | +$1.25M | 0.2% | 93 |
|
Other funds holding CVS
Pekin Hardy Strauss's CVS Position: Q2 2026 in Review
Pekin Hardy Strauss held its CVS Health (CVS) position steady in Q2 2026 at 4,125 shares worth $427K. The position accounts for 0.04% of the portfolio, ranked #339.
Pekin Hardy Strauss first reported a position in CVS in Q4 2014 and has held it in 41 quarters since. The position peaked at $2.26M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Pekin Hardy Strauss held 4,125 shares of CVS Health worth $427K as of Q2 2026.
- Pekin Hardy Strauss left its CVS Health share count unchanged in Q2 2026.
- CVS Health made up 0.04% of Pekin Hardy Strauss's portfolio in Q2 2026, its #339 holding.
- Pekin Hardy Strauss first reported a position in CVS Health in Q4 2014 and has held it in 41 quarters since.
- Pekin Hardy Strauss's CVS Health position peaked at $2.26M in Q4 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Pekin Hardy Strauss's 13F filing for Q2 2026, filed 30 Jul 2026.